Do testosterone and estradiol levels decline in aging men?

The relationship between aging and male sex steroids is characterized by a gradual but significant shift in the endocrine landscape, driven by both central and peripheral physiological changes.

Clinical evidence of hormonal decline

Scientific evidence strongly supports the decline of testosterone as a hallmark of male aging, while the trend for estradiol is more nuanced but generally shows a reduction in biological availability.

• Testosterone: Longitudinal studies, such as the Baltimore Longitudinal Study of Aging, demonstrate that total testosterone levels decline at a rate of approximately 1% to 2% annually starting around age 30. By age 70, nearly 30% of men meet the biochemical criteria for hypogonadism, and approximately 50% show low levels of "free" (biologically active) testosterone.
• Estradiol: Because approximately 80% of male estradiol is derived from the peripheral aromatization of testosterone, its levels are closely linked to its precursor. While total estradiol levels may appear stable or even slightly elevated in older men due to increases in body fat (which contains aromatase) and Sex Hormone-Binding Globulin (SHBG), the free estradiol fraction consistently declines. In many older men, bioavailable estradiol levels fall significantly, often approaching or dropping below detection limits.

Mechanistic explanations

The decline in these hormones is the result of systematic failures across the hypothalamic-pituitary-gonadal (HPG) axis and changes in peripheral metabolism.

• HPG Axis Failure: Aging involves a central reduction in gonadotropin-releasing hormone (GnRH) and impaired luteinizing hormone (LH) secretion. This results in less stimulation of the testes to produce testosterone.
• Leydig Cell Senescence: At the testicular level, the number of Leydig cells decreases, and those that remain show reduced responsiveness to LH. This is driven by mitochondrial dysfunction and the downregulation of steroidogenic proteins like StAR and CYP11A1.
• Substrate Scarcity: As testosterone levels fall, the total amount of substrate available for conversion into estradiol decreases. This "substrate scarcity" is a primary driver of declining free estradiol in older men, even if the body's aromatase enzyme (which converts testosterone to estradiol) remains active or increases in adipose tissue.

Bottom line

In aging men, testosterone levels decline predictably due to both primary testicular and secondary central dysfunction. While total estradiol may appear stable due to compensatory mechanisms like increased fat mass, the bioavailable (free) estradiol fraction typically declines alongside testosterone, representing a significant change in the overall hormonal environment for men in their 70s.